HemaTox™ Myeloid Kit

Serum-free medium and supplement for the measurement of drug toxicity on myeloid cells
HemaTox™ Myeloid Kit

Serum-free medium and supplement for the measurement of drug toxicity on myeloid cells

1 Kit
Catalog # 09704
732 EUR

Overview

Screen large numbers of novel drug compounds for their effect on the proliferation and myeloid-specific differentiation of human hematopoietic stem and progenitor cells (HSPCs).

Compared to using the colony-forming unit (CFU) assay, the liquid culture-based HemaTox™ assay is more flexible: you can add test compounds at various points throughout the culture and measure their effects on more primitive or more mature progenitor cells. The HemaTox™ Myeloid Kit promotes the proliferation of CD34+ HSPCs and their differentiation into cells expressing myeloid markers such as CD13, CD14, and CD15.

Users can choose the readout method to quantify the response and estimate the IC50 and IC90 of each compound tested. Test up to 160 conditions—in triplicate—per kit in 5 x 96-well plates. This kit may be used on its own or in combination with HemaTox™ Erythroid Kit (Catalog #09701) or HemaTox™ Megakaryocyte Kit (Catalog #09707) to assess lineage-specific drug toxicity in parallel.
Components
  • HemaTox™ Myeloid Medium, 100 mL
  • HemaTox™ Myeloid 100X Supplement, 1 mL
Subtype
Specialized Media
Cell Type
Hematopoietic Stem and Progenitor Cells, Myeloid Cells
Species
Human
Application
Cell Culture, Toxicity Assay
Brand
HemaTox
Area of Interest
Drug Discovery and Toxicity Testing, Stem Cell Biology
Formulation
Serum-Free

Scientific Resources

Product Documentation

Document Type Product Name Catalog # Lot # Language
Document Type
Product Information Sheet
Product Name
HemaTox™ Myeloid Kit
Catalog #
09704
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Product Name
HemaTox™ Myeloid Kit
Catalog #
09704
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Product Name
HemaTox™ Myeloid Kit
Catalog #
09704
Lot #
All
Language
English

Educational Materials (4)

Brochure
Hematopoietic Stem and Progenitor Cells - Products for Your Research
Technical Bulletin
Media and Supplements for In Vitro Hematotoxicity Testing
Webinar
Anticipating Cytopenia: In Vitro Methods for Hematotoxicity Testing
55:33
Anticipating Cytopenia: In Vitro Methods for Hematotoxicity Testing
Scientific Poster
A Flexible 96-Well Plate Assay for Screening Toxicity to Granulocyte Production

Data and Publications

Data

Figure 1. General HemaTox™ Myeloid Kit Procedure

*The cell isolation step may be omitted if pre-enriched CD34+ cells are used.

Figure 2. Flow Cytometry Plot Showing Cells Produced After Culture of CD34+ HSPCs with the HemaTox™ Myeloid Kit

(A) Human CB CD34+ cells were cultured with the HemaTox™ Myeloid Kit using the protocol as written in the Product Information Sheet (PIS). (B) After the appropriate culture period, cells were harvested and stained for cell surface proteins expressed on myeloid (CD13 and CD15) cells.

Figure 3. Reproducibility of HemaTox™ Myeloid Kit Results Between Experiments and Using Different CD34+ Cell Preparations

(A) Dose-response curves were generated from titrations of 5-FU added to human CB CD34+ cells isolated from 3 donors and cultured with the HemaTox™ Myeloid Kit. Three to five separate experiments were performed with cells from each donor. In each assay similar IC50 values were obtained with cells from different donors and in different experiments with cells from the same donor. Shown are values normalized to the percentages (%) of maximum cell growth without drug. Despite differences in absolute cell counts, curves are reproducible when normalized within each experiment. (B) Table showing IC50 values generated for 5-FU in culture with the myeloid kit including standard deviation (SD) and the coefficient of variation (% CV) across experiments.

Figure 4. Correlation Between IC50 Values for Six Drugs Measured Using the CFU-GM Assay and the 96-Well Plate Liquid Culture-Based HemaTox™ Myeloid Kit

Human BM CD34+ cells were cultured in colony-forming unit - granulocyte/macrophage (CFU-GM) assays with MethoCult™ medium and in liquid culture with the HemaTox™ Myeloid Kit. IC50 values generated using each assay were plotted on the X and Y axes and shown to be highly correlated with a coefficient of determination (R2) of 0.91.

Figure 5. Lineage-Specific Differences in Hematotoxicity Identified with HemaTox™ Erythroid, Myeloid and Megakaryocyte Kits

Results show average IC50 values for each drug tested on human BM CD34+ cells using the HemaTox™ Erythroid (grey), Myeloid (gold) and Megakaryocyte (orange) Kits. Most drugs show similar toxicity for each lineage but some, such as Sunitinib, are ~100-fold more toxic for erythroid than for megakaryocyte progenitor differentiation with intermediate toxicity for myeloid progenitor differentiation. Vertical lines indicate standard error of the mean (SEM) (n = 4 - 8).

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.